Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Cancer-related fatigue
doi: 10.1530/REP-15-0044 149 MaXHayesEPrizantHSrivastavaRKHammesSRSenAet al
To learn more about this report, Glucagon Like Peptide 1 Analogs Market Insights, By Brand - Saxenda commands the highest share of the market driven by its targeted weight management positioning and brand recognition Saxenda is expected to lead the glucagon like peptide 1 analogs market by brand largely because of its established presence as an effective weight management therapy for obesity and overweight adults with share of 21.1% in 2026
Very Rare Side Effects Some study participants reported mild injection-site irritation, including temporary sensitivity or tingling in a small number of cases
However, excessive pregnancy weight gain (defined as more than recommended ranges by pre-pregnancy BMI) increases risks for gestational diabetes, preeclampsia, and postpartum weight retention
US$ 20.18
US$ 29.82
US$ 22.51
US$ 21.34
